Invention Grant
- Patent Title: HCV protease inhibitors
- Patent Title (中): HCV蛋白酶抑制剂
-
Application No.: US12559818Application Date: 2009-09-15
-
Publication No.: US08389560B2Publication Date: 2013-03-05
- Inventor: Chen-Fu Liu , Kuang-Yuan Lee , Pei-Chin Cheng , Yo-Chin Liu , Pin Lo , Kuo-Feng Tseng , Chih-Ming Chen , Chi-Hsin Richard King , Chu-Chung Lin
- Applicant: Chen-Fu Liu , Kuang-Yuan Lee , Pei-Chin Cheng , Yo-Chin Liu , Pin Lo , Kuo-Feng Tseng , Chih-Ming Chen , Chi-Hsin Richard King , Chu-Chung Lin
- Applicant Address: TW Taipei
- Assignee: TaiGen Biotechnology Co., Ltd.
- Current Assignee: TaiGen Biotechnology Co., Ltd.
- Current Assignee Address: TW Taipei
- Agency: Occhiuti Rohlicek & Tsao LLP
- Main IPC: A61K31/407
- IPC: A61K31/407 ; C07D245/04 ; C07D401/12
Abstract:
This invention relates to macrocyclic compounds of formula (I) shown in the specification. These compounds can be used to treat hepatitis C virus infection.
Public/Granted literature
- US20110065737A1 HCV PROTEASE INHIBITORS Public/Granted day:2011-03-17
Information query
IPC分类:
